Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Retin Cases Brief Rep. 2016 Fall;10(4):357–360. doi: 10.1097/ICB.0000000000000262

Figure 2.

Figure 2

Patient 2 showing response of retinal disease to intravitreal melphalan. Left: Following three courses of ophthalmic artery chemosurgery (OAC), the right eye of patient 2 shows active tumor extending from the main calcified tumor. Right: Right eye of patient 2 with calcific tumor regression following 7 injections of intravitreal melphalan.